Unlock instant, AI-driven research and patent intelligence for your innovation.

Applications of LINCR-0001 in preparation of gastric cancer diagnostic products and treatment drugs

A product, gastric cancer technology, applied in the field of biomedicine, can solve problems such as poor prognosis and achieve the effect of improving survival rate

Inactive Publication Date: 2020-04-03
QINGDAO MEDINTELL BIOMEDICAL CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The rapid progression and metastasis of the disease lead to poor prognosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Applications of LINCR-0001 in preparation of gastric cancer diagnostic products and treatment drugs
  • Applications of LINCR-0001 in preparation of gastric cancer diagnostic products and treatment drugs

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048] Example 1 Differentially expressed LncRNA research

[0049] 1. Research object

[0050] Surgical specimens (gastric cancer tissues and corresponding adjacent normal tissues) of 50 patients with primary gastric cancer who underwent radical gastrectomy in the Department of Oncology of the hospital were collected. Among the 50 patients, there were 30 males and 20 females; their age ranged from 38 to 79 years, with an average of 61 years old. None of the patients had received adjuvant therapy before operation. Immediately after RNA extraction, tissue samples were stored at -80°C.

[0051] Inclusion criteria: a. Preoperative diagnosis of primary gastric cancer, and no tumor treatment; b. No other malignant tumors; c. No other complications, such as gastric perforation, gastrointestinal bleeding, gastrointestinal obstruction, etc. The general condition of the patient was good before operation; d. No other chronic diseases, such as hypertension, diabetes, etc.

[0052] 2. D...

Embodiment 2

[0056] Example 2 inhibits the expression of LINCR-0001

[0057] 1. Cell culture and transfection

[0058] Cell culture: Gastric cancer cell line BGC-823 was used in DMEM containing 10% FBS and placed in 5% CO 2 , Saturated humidity, cultured in a 37°C carbon dioxide incubator. The culture medium was changed every two days, and the cells were digested with 0.25% trypsin when subcultured.

[0059] siRNA transfection: The day before transfection, cells are digested and inoculated into culture dishes or culture plates, and the number of cells inoculated should ensure that the density of 30-50% can be reached on the second day of transfection. siRNA transfection strictly according to Lipofectamin TM According to the 2000 specification, after 4-6 hours, replace with fresh culture medium containing 10% FBS, and continue to cultivate for 48 hours.

[0060] 2. siRNA design

[0061] Design of siRNA (small interfering RNA): siRNA sequence was designed in the specific sequence region...

Embodiment 3

[0070] Example 3 Determination of Inhibition of LINCR-0001 Expression on the Proliferative Ability of Gastric Cancer Cells

[0071] 1. Steps:

[0072] BGC-823 cells in the logarithmic growth phase were seeded on 96-well culture plates. After 12 hours of culture, the cells were transfected with siRNA-LncRNA and siRNA-NC respectively. After 4-6 hours, DMEM containing 10% FBS was replaced and cultured for 72 hours. Add 10 μL CCK8 to each well of each plate, incubate in the incubator for 2 hours, and then use a microplate reader to detect the absorbance value at a wavelength of 450 nm. Five replicate wells were set up for each group of cells, the experiment was repeated 3 times, and the cell growth curve was drawn.

[0073] 2. Statistical analysis

[0074] The experimental data were expressed as mean ± standard deviation, and SPSS15.0 statistical software was used to conduct one-way analysis of variance (ANOVA) or t test. P<0.05 means the difference is statistically significant...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of genetic engineering, and especially relates to applications of LINCR-0001 in preparation of gastric cancer diagnostic products and treatment drugs. In addition, the invention relates to related primers and a diagnostic kit. The relation between LINCR-0001 and pathogenesis of gastric cancer can be revealed by studying the expression of long-chain non-coding RNAcell levels.

Description

technical field [0001] The invention belongs to the field of biomedicine, and relates to the use of LINCR-0001 in preparing gastric cancer diagnostic products and therapeutic drugs. Background technique [0002] Gastric cancer (GC) is the second leading cause of cancer death worldwide. The rapid progression and metastasis of the disease lead to poor prognosis. To improve the early diagnosis and targeted therapy of GC, there is an urgent need to understand its underlying molecular mechanism and identify novel and effective novel biomarkers and therapeutic targets. [0003] Long non-coding RNAs (lncRNAs) are a class of RNA molecules with a transcript length of more than 200 nt, which are different from other small non-coding RNAs in that they can regulate RNA in cis or in trans Metabolism, protein functional activity, histone modification, and chromatin remodeling are involved in a wide range of cellular biological processes at the epigenetic, transcriptional, and post-trans...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6886C12Q1/02A61K45/00A61K31/713A61P35/00A61K49/00
CPCA61K31/713A61K45/00A61K49/0008A61P35/00C12Q1/6886C12Q2600/118C12Q2600/136C12Q2600/158C12Q2600/178G01N33/5011
Inventor 杨承刚陈丽媛
Owner QINGDAO MEDINTELL BIOMEDICAL CO LTD